ADCT: ADC Therapeutics SA insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | New 13G stake | Nantahala Capital Management, LLC | 9.69% | SEC | |
| 2026-07-27 | New 13G stake | BlackRock, Inc. | 5.40% | SEC |
Institutional ownership (Q2 2026)
113 institutions reported holding $99.35M of ADC Therapeutics SA on Form 13F (118 the quarter before). 26 opened a new position and 30 sold out. Shares held by institutions: +11%.
| Largest holders | Shares | Value |
|---|---|---|
| Nantahala Capital Management, LLC | 24,652,368 | $26.38M |
| Redmile Group, LLC | 11,526,710 | $12.33M |
| TCG Crossover Management, LLC | 11,390,175 | $12.19M |
| Prosight Management, LP | 7,824,749 | $8.37M |
| BlackRock, Inc. | 7,020,093 | $7.51M |
| Point72 Asset Management, L.P. | 3,649,144 | $3.90M |
| MORGAN STANLEY | 3,051,173 | $3.26M |
| MILLENNIUM MANAGEMENT LLC | 2,899,535 | $3.10M |
| CITADEL ADVISORS LLC | 2,053,316 | $2.20M |
| GOLDMAN SACHS GROUP INC | 1,914,424 | $2.05M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.